Among patients with T2DM who had a reduced eGFR, those with NADKD had a shorter duration of diabetes and a lower level of SBP, DBP, PP, TC, ApoB, ApoB/ApoAI, and prevalence of anemia than patients with AGDKD (Table 1). This evidence concerns the gene APOA1 and type 2 diabetes mellitus.